4-Amino-1-[6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]pyrimidin-2-one | 362-42-5

• 物质功能分类: 分析化学 - 标准品 - 药典标准品和杂质标准品
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 4-Amino-1-[6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]pyrimidin-2-one
• CAS: 362-42-5
• 化学式: C₁₂H₁₇N₃O₅
• 分子量: 283.28
• InChiKey: UBGDNZQSYVIVHU-UHFFFAOYSA-N

物化性质

• 熔点：
  238-240℃ (methanol )
• 沸点：
  465.7±55.0 °C(Predicted)
• 密度：
  1.66±0.1 g/cm3 (20℃ 760 Torr)

计算性质

• 辛醇/水分配系数(LogP)：
  -1.6
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  107
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• A SET OF GELDANAMYCIN DERIVATIVES AND THEIR PREPARATION METHODS
  申请人：Institute Of Medicinal Biotechnology, Chinese Academy of Medical Sciences

  公开号：EP2253621A1

  公开（公告）日：2010-11-24

  A set of geldanamycin derivatives and their preparation methods. Pharmaceutical compositions comprising the said compounds as an active ingredient which are used as antivirus and antitumor agents. The said derivatives are used in the manufacture of heat shock protein 90(Hsp 90) inhibiting agents which have the utility as antivirus and antitumor agents.

  一组格尔丹霉素衍生物及其制备方法。包含所述化合物作为活性成分的药物组合物，用作抗病毒和抗肿瘤药剂。所述衍生物用于制造具有抗热休克蛋白90（Hsp 90）抑制作用的药剂，具有作为抗病毒和抗肿瘤药剂的用途。
• [EN] DEAMINATION OF ORGANOPHOSPHORUS-NUCLEOSIDES<br/>[FR] DÉSAMINATION DE NUCLÉOSIDES ORGANOPHOSPHORÉS
  申请人：INST UNIV DE CIÈNCIA I TECNOLOGIA S A

  公开号：WO2016146808A1

  公开（公告）日：2016-09-22

  The invention relates to a new synthethic process for obtaining compounds of formula (I) from compounds of formula (II) by means of cytidine deaminase enzymes.

  这项发明涉及一种新的合成过程，通过胞嘧啶脱氨酶酶将式(I)化合物从式(II)化合物中获得。
• [EN] N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO<br/>[FR] N4-HYDROXYCYTIDINE ET SES DÉRIVÉS ET UTILISATIONS ANTIVIRALES ASSOCIÉES
  申请人：UNIV EMORY

  公开号：WO2021159044A1

  公开（公告）日：2021-08-12

  This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of human coronavirus 2019-nCoV.

  这项披露涉及某些N4-羟基胞苷衍生物、药物组合物以及相关方法。在某些实施方式中，该披露涉及治疗或预防人类冠状病毒2019-nCoV。
• Set of Geldanamycin Derivatives and Their Preparation Methods
  申请人：Li Zhuorong

  公开号：US20100311694A1

  公开（公告）日：2010-12-09

  A set of geldanamycin derivatives and their preparation methods. Pharmaceutical compositions comprising the said compounds as an active ingredient which are used as antivirus and antitumor agents. The said derivatives are used in the manufacture of heat shock protein 90 (Hsp 90) inhibiting agents which have the utility as antivirus and antitumor agents.

  一组格尔达纳霉素衍生物及其制备方法。包含所述化合物作为活性成分的制药组合物，用作抗病毒和抗肿瘤剂。所述衍生物用于制造抑制热休克蛋白90（Hsp 90）的药剂，具有作为抗病毒和抗肿瘤剂的功效。
• N4-hydroxycytidine and derivatives and anti-viral uses related thereto
  申请人：Emory University

  公开号：US10874683B2

  公开（公告）日：2020-12-29

  This disclosure relates to certain N4-hydroxycytidine derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of a Zika virus infection.

  本公开涉及某些 N4-羟基胞嘧啶衍生物、组合物及其相关方法。 在某些实施方案中，本公开涉及寨卡病毒感染的治疗或预防。